France (2) Costs (2) Assaying (2) Diseases (2) Impact (2) Analysis (2) Morbilidad (2) Enfermedades (2) Analyse (2) Impact (2) Analyse (2) Coût (2) Maladies (2) France (2) Paris (1) Development (1) Adjuvant treatment (1) Chemical warfare (1) Cost effectiveness (1) Cancer (1) Communication (1) Docetaxel (1) Price-earnings ratio (1) Rare diseases (1) Horizon (1) Women patients (1) Year (1) Worms (1) Warranty (1) Time (1)